The global Orthobiologics Market is projected to be valued at USD 5,762.7 million in 2025, reaching USD 8,287.3 million by 2035, with a compound annual growth rate (CAGR) of 3.7% during the forecast period. Growth is underpinned by the increasing incidence of musculoskeletal conditions such as osteoarthritis, fractures, and spinal disorders, particularly in aging and …
Continue reading “Orthobiologics Market to Hit USD 8.3M by 2035”